Home > News > BioSante Pharmaceuticals To Present At Investor Conference
February 23rd, 2004
BioSante Pharmaceuticals To Present At Investor Conference
BioSante Pharmaceuticals announced today that Stephen M. Simes, its president and chief executive officer, is scheduled to present at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York on Wednesday, February 25, at 9:30 a.m. EST. Mr. Simes will discuss BioSante's progress with its hormone therapy products and its nanotechnology-based drug and vaccine delivery systems.
Study shows how water dissolves stone, molecule by molecule: International team uses computers, experiments to better predict chemical dissolution December 5th, 2013
Laser light at useful wavelengths from semiconductor nanowires: Nanowire lasers could work with silicon chips, optical fibers, even living cells December 5th, 2013
DNA helicity and elasticity explained on the nanoscale: Korean researchers propose simple model to explain DNA helicity and elasticity on a nanometer scale December 5th, 2013
3-D printing and custom manufacturing: from concept to classroom: Strategic investments from NSF help engineers revolutionize the manufacturing process December 5th, 2013